1. |
Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management and prevention of Chronic Obstructive Pulmonary Disease. (2021 REPORT). Available at: https://goldcopd.org/gold-reports/.
|
2. |
Barbosa MT, Sousa CS, Morais-Almeida M, et al. Telemedicine in COPD: an overview by topics. COPD, 2020, 17(5): 601-617.
|
3. |
Brandsma CA, Van den Berge M, Hackett TL, et al. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. J Pathol, 2020, 250(5): 624-635.
|
4. |
陶晶, 谢田刚, 栾桂红. 急性加重期慢性阻塞性肺疾病患者血清 ChE、LTB4、BNP 水平变化及临床意义. 山东医药, 2019, 59(22): 8-11.
|
5. |
Ding GZ, Li WS. The expressions and significance of APN, D-D, IL-17 and hs-CRP in patients with acute exacerbation of chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci, 2018, 22(19): 6463-6468.
|
6. |
肖光军, 李祥坤, 魏容, 等. 血液中 PLR、NLR 及 D-二聚体水平对 AECOPD 患者的预后价值评估. 检验医学与临床, 2019, 16(8): 1067-1070.
|
7. |
Husebø GR, Gabazza EC, D'Alessandro Gabazza C, et al. Coagulation markers as predictors for clinical events in COPD. Respirology, 2021, 26(4): 342-351.
|
8. |
Teng F, Ye H, Xue TJ. Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease. PLoS One, 2018, 13(9): e204377.
|
9. |
王丽芳, 韩寒, 施斌. 红细胞分布宽度联合中性粒细胞/淋巴细胞比值对慢性阻塞性肺疾病急性加重期患者预后的评估价值. 中国医药导报, 2020, 17(35): 34-37.
|
10. |
Aksoy E, Karakurt Z, Gungor S, et al. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes. Int J Chron Obstruct Pulmon Dis, 2018, 13: 2721-2730.
|
11. |
El-Gazzar AG, Kamel MH, Elbahnasy O, et al. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients. Expert Rev Respir Med, 2020, 14(1): 111-116.
|
12. |
Luo ZB, Zhang W, Chen LN, et al. Prognostic value of neutrophil: lymphocyte and platelet: lymphocyte ratios for 28-day mortality of patients with AECOPD. Int J Gen Med, 2021, 14: 2839-2848.
|
13. |
Lu FY, Chen R, Li N, et al. Neutrophil-to-lymphocyte ratio predicts clinical outcome of severe acute exacerbation of COPD in frequent exacerbators. Int J Chron Obstruct Pulmon Dis, 2021, 16: 341-349.
|
14. |
Kyriakopoulos C, Gogali A, Kostikas K, et al. Hypercoagulable state in COPD-a comprehensive literature review. Diagnostics (Basel), 2021, 11(8): 1447.
|
15. |
陈金来, 张菊英, 秦红, 等. 血清 D-二聚体水平对预测老年慢性阻塞性肺疾病患者预后的价值. 检验医学, 2021, 36(3): 309-312.
|
16. |
李湘, 罗燕青, 曲雷. D-二聚体水平与慢性阻塞性肺疾病急性加重期预后的关系研究. 国际检验医学杂志, 2018, 39(5): 595-597,601.
|
17. |
Hu GP, Wu Y, Zhou Y, et al. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2729-2736.
|
18. |
Ruocco G, Evangelista I, Franci B, et al. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome. J Cardiovasc Med (Hagerstown), 2019, 20(2): 81-90.
|
19. |
Amsallem M, Sweatt AJ, Arthur AJ, et al. Targeted proteomics of right heart adaptation to pulmonary arterial hypertension. Eur Respir J, 2021, 57(4): 2002428.
|
20. |
Vallabhajosyula S, Haddad TM, Sundaragiri PR, et al. Role of B-type natriuretic peptide in predicting in-hospital outcomes in acute exacerbation of chronic obstructive pulmonary disease with preserved left ventricular function: a 5-year retrospective analysis. J Intensive Care Med, 2018, 33(11): 635-644.
|
21. |
Li HQ, Zeng Z, Cheng J, et al. Prognostic role of NT-proBNP for in-hospital and 1-year mortality in patients with acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis, 2020, 15: 57-67.
|